Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Medical Oncology
•
Immune-related adverse events
•
Neurology
•
Neuromuscular
How do you manage immunotherapy-induced myasthenia gravis?
Answer from: at Academic Institution
My go-to algorithm is well-represented in the paper by Dr. @Adeel Zubair et al. Zubair et al., PMID 36439604
Sign in or Register to read more
Answer from: Medical Oncologist at Community Practice
NCCN "Management of Immunotherapy-Related Toxicities" has a useful 'cheat sheet' as a quick reference for the overnight call.
Sign in or Register to read more
19074
19390
Related Questions
How does one interpret an SPEP showing potentially obscured but non-quantifiable M-spike however an IFE showing monoclonal protein?
Do you prescribe respiratory muscle training (RMT) devices to patients with dysphagia?
What is your approach to a child with toe walking with a reassuring exam but a family history of difficulty walking?
When do you consider testing autoimmune antibodies for axonal polyneuropathies without clear etiology?
What do you consider when there is incidentally found patchy peripheral nerve enlargement on imaging with otherwise unremarkable clinical and electrophysiological findings?
In what circumstances would you consider use of IDH inhibitors in high-grade astrocytomas?
What strategies do you find helpful in advanced care planning with patients/families who are very "miracle" centered?
What leads you to suspect that a foot drop is secondary to a myopathy rather than a neuropathic process?
What infections should we rule out in patients who develop diarrhea on immunotherapy?
To what extent do you incorporate electrodiagnostic testing and ultrasonography in your clinical practice for evaluating suspected cases of meralgia paresthetica?